Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Nov;186(5):1830-4.
doi: 10.1016/j.juro.2011.06.057. Epub 2011 Sep 23.

Complications after prostate biopsy: data from SEER-Medicare

Stacy Loeb  1 , H Ballentine Carter, Sonja I Berndt, Winnie Ricker, Edward M Schaeffer
Affiliations

Complications after prostate biopsy: data from SEER-Medicare

Stacy Loeb et al. J Urol. 2011 Nov.

Abstract

Purpose: More than 1 million prostate biopsies are performed annually among Medicare beneficiaries. We determined the risk of serious complications requiring hospitalization. We hypothesized that with emerging multidrug resistant organisms there may be an increasing risk of infectious complications.

Materials and methods: In a 5% random sample of Medicare participants in SEER (Surveillance, Epidemiology and End Results) regions from 1991 to 2007 we compared 30-day hospitalization rates and ICD-9 primary diagnosis codes for admissions between 17,472 men who underwent prostate biopsy and a random sample of 134,977 controls. Multivariate logistic and Poisson regression were used to examine the risk and predictors of serious infectious and noninfectious complications with time.

Results: The 30-day hospitalization rate was 6.9% within 30 days of prostate biopsy, which was substantially higher than the 2.7% in the control population. After adjusting for age, race, SEER region, year and comorbidities prostate biopsy was associated with a 2.65-fold (95% CI 2.47-2.84) increased risk of hospitalization within 30 days compared to the control population (p <0.0001). The risk of infectious complications requiring hospitalization after biopsy was significantly greater in more recent years (p(trend) = 0.001). Among men undergoing biopsy, later year, nonwhite race and higher comorbidity scores were significantly associated with an increased risk of infectious complications.

Conclusions: The risk of hospitalization within 30 days of prostate biopsy was significantly higher than in a control population. Infectious complications after prostate biopsy have increased in recent years while the rate of serious noninfectious complications is relatively stable. Careful patient selection for prostate biopsy is essential to minimize the potential harms.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
30-day frequency of (a) overall hospitalizations, (b) hospitalizations with infection as the primary diagnosis, and (c) hospitalizations with non-infectious biopsy-related complications as the primary diagnosis in the biopsy (black circle) and control (gray squares) groups.
See this image and copyright information in PMC

Comment in

References

    1. American Cancer Society. Cancer Facts & Figures 2009 http://www.cancer.org/downloads/STT/500809web.pdf. Accessed October 7, 2009.
    1. Prostate Cancer. In: Litwin MS and Saigal CS, editors. Urologic Disease in America US Dept of Health and Human Services, Public Health Service, NIG, NIDDK. Washington DC: US Government Publishing Office, 2007; NIH Publication No. 07–5512 [p.76].
    1. Welch HG, Fisher ES, Gottlieb DJ et al.: Detection of prostate cancer via biopsy in the Medicare-SEER population during the PSA era. J Natl Cancer Inst, 99: 1395, 2007 - PubMed
    1. Ozden E, Bostanci Y, Yakupoglu KY et al.: Incidence of acute prostatitis caused by extended-spectrum beta-lactamase-producing Escherichia coli after transrectal prostate biopsy. Urology, 74: 119, 2009 - PubMed
    1. Al-Hasan MN, Lahr BD, Eckel-Passow JE et al.: Antimicrobial resistance trends of Escherichia coli bloodstream isolates: a population-based study, 1998–2007. J Antimicrob Chemother, 64: 169, 2009 - PMC - PubMed

Publication types